Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00468325 · ClinicalTrials.gov registry record · NA
Coronary Computed Tomography for Systematic Triage of Acute Chest Pain Patients to Treatment (CT-STAT)
A NA study of Chest Pain and Coronary Angiography, sponsored by Corewell Health East.
- Completed
- Registry status
- NA
- Development phase
- 750
- Enrollment target
- 16
- Study locations
NCT00468325: Completed NA study of Chest Pain and Coronary Angiography, sponsored by Corewell Health East.
NCT00468325 is a NA study of Chest Pain and Coronary Angiography that has completed, run by Corewell Health East. The registered enrollment target is 750 participants, below the 1,424-participant average among 22 other Chest Pain trials with a reported enrollment target (47% lower). The trial reports 16 study locations across 14 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00468325, a NA study of Chest Pain and Coronary Angiography, has completed, sponsored by Corewell Health East.
- COMPLETED
- Registry status
- NA
- Development phase
- 750 participants
- Enrollment target
- 16
- Study locations
Study Summary
This is a prospective, randomized multicenter trial comparing MSCT to standard of care (SOC) diagnostic treatment in the triage of Emergency Department (ED) low to intermediate risk chest pain patients. Our hypotheses are that compared to SOC treatment, MSCT is equally safe and diagnostically effective, as well as more time and cost efficient.
Conditions Studied
Interventions
- PROCEDURE Multi-slice computed tomography
- PROCEDURE Rest-stress Nuclear Myocardial Perfusion Imaging
- PROCEDURE Multi-slice Computed Tomography
Study Locations (16)
Michigan
- William Beaumont Hospital - Royal Oak
- William Beaumont-Troy - Troy
Minnesota
- Minneapolis Heart Institute - Minneapolis
- St. Paul Heart Clinic - Saint Paul
California
- Cedars-Sinai Medical Center - Los Angeles
District of Columbia
- Washington Hospital Center - Washington D.C.
Florida
- Cleveland Clinic Florida - Weston
Georgia
- Faqua Heart Center/Piedmont Hospital - Atlanta
Illinois
- Northwestern Memorial Hospital - Chicago
Massachusetts
- Massachusetts General Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 750 participants |
| Start Date | 2007-05 |
| Est. Completion | 2009-05 |
| Phase | NA |
What the finished NCT00468325 record still lists
NCT00468325 is an interventional study that assigns participants to a tested intervention. The registered 750 participants enrollment target is mid-sized for trials with a published cap, below the 1,424-participant average among 22 other Chest Pain trials with a reported enrollment target (47% lower).
The record links to 2 conditions, with Chest Pain appearing as the primary indexed condition, and to 3 interventions - of which Multi-slice computed tomography is the first listed.
NCT00468325 lists 16 locations in 14 states (Michigan, Minnesota, California).
Frequently Asked Questions
What is clinical trial NCT00468325 about?
NCT00468325 is a clinical study titled "Coronary Computed Tomography for Systematic Triage of Acute Chest Pain Patients to Treatment (CT-STAT)". This is a prospective, randomized multicenter trial comparing MSCT to standard of care (SOC) diagnostic treatment in the triage of Emergency Department (ED) low to intermediate risk chest pain patients. Our hypotheses are that compared to SOC treatment, MSCT is equally safe and diagnostically effect...
What is the current status of trial NCT00468325?
This trial is currently completed. It is a NA study. The enrollment target is 750 participants. The study started on 2007-05. Estimated completion is 2009-05.
What conditions does trial NCT00468325 study?
This clinical trial studies the following conditions: Chest Pain, Coronary Angiography.
What interventions are being tested in trial NCT00468325?
The interventions under investigation include: Multi-slice computed tomography (PROCEDURE), Rest-stress Nuclear Myocardial Perfusion Imaging (PROCEDURE), Multi-slice Computed Tomography (PROCEDURE).
Who is sponsoring clinical trial NCT00468325?
This trial is sponsored by Corewell Health East, which has 106 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00468325 being conducted?
This trial has 16 study locations across California, District of Columbia, Florida, Georgia, Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Chest Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00468325's enrollment target sits among peer trials
750 5th of 22 higher than 18 of 22 other Chest Pain trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Chest Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Virtual Reality for Non-cardiac Chest Pain
RECRUITING · NA
-
CARE-CP (Testing a Cardiovascular Ambulatory Rapid Evaluation for Patients With Chest Pain)
RECRUITING · NA
-
Intraoperative Echocardiography in Low-Risk CABG Surgery
ACTIVE NOT RECRUITING · NA
-
Patient-centered Treatment of Anxiety After Low-Risk Chest Pain in the Emergency Room
ACTIVE NOT RECRUITING · NA
-
Comparing Sports Bra Design in Full Busted Women
COMPLETED · NA
-
Chest Pain Perception and Capsaicin Sensitivity
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02048332 · 750 participants · Phase 1
Donor-Derived Viral Specific T-cells (VSTs)
- NCT02087852 · 750 participants
Kidney Cancer DNA Registry
- NCT02532452 · 750 participants · Phase 2
Third Party Viral Specific T-cells (VSTs)
- NCT03126916 · 750 participants · Phase 3
Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia